Wiskott–Aldrich syndrome and X-linked thrombocytopenia: a review of the clinical and immunological spectrum with a case presentation highlighting glomerulonephritis - Report - MDSpire
Advertisement
Wiskott–Aldrich syndrome and X-linked thrombocytopenia: a review of the clinical and immunological spectrum with a case presentation highlighting glomerulonephritis
Clinical Report: Insights into Wiskott–Aldrich Syndrome and Glomerulonephritis
Overview
This report presents a case of a 10-year-old boy with Wiskott–Aldrich syndrome (WAS) exhibiting severe thrombocytopenia and IgA nephropathy. It emphasizes the importance of recognizing renal involvement in WAS and highlights the need for genetic confirmation and multidisciplinary management.
Background
Wiskott–Aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency characterized by a triad of symptoms: thrombocytopenia, eczema, and recurrent infections. Renal involvement, particularly glomerulonephritis, is uncommon but can significantly impact patient outcomes. Understanding the autoimmune manifestations associated with WAS is crucial for timely diagnosis and management.
Data Highlights
No numerical data provided in the article.
Key Findings
The patient presented with severe thrombocytopenia, hyporegenerative anemia, and nephritic-range proteinuria.
Genetic testing confirmed a homozygous c.599+5G>A WAS variant, consistent with X-linked thrombocytopenia (XLT).
Kidney biopsy revealed IgA nephropathy with 30% interstitial fibrosis.
Autoantibodies including antiglomerular basement membrane and antinuclear antibodies were detected in the patient.
Registry data indicated that WAS patients often experience diverse autoimmune manifestations, including renal involvement.
Clinical Implications
Healthcare professionals should be vigilant in recognizing renal complications in patients with WAS/XLT. Early genetic confirmation and a multidisciplinary approach are essential for managing these patients effectively.
Conclusion
This case underscores the broad spectrum of autoimmune manifestations in WAS/XLT, particularly the potential for renal involvement, and highlights the importance of early diagnosis and comprehensive management.